This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Gacci M, Corona G, Salvi M et al (2012) A systematic review and meta-analysis on the use of Phosphodiesterase 5 inhibitors alone or in combination with a-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 61: 994–1003
Inder WJ, Castle D (2011) Antipsychotic-induced hyperprolactinaemia. Aust N Z J Psychiatry; 45: 830–837
Malik P, Kemmler G, Hummer M et al; and the EUFEST Study Group (2011) Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol 31: 274–280
Melnik T, Althof S, Atallah AN et al (2011) Psychosocial interventions for premature ejaculation.Cochrane Database Syst Rev 8: CD008195
Moll JL, Brown CS (2011) The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature. J Sex Med 8: 956–970
Müller MJ (2011) Sexuelle Funktionsstörungen - Wenn Psychopharmaka das Liebesleben lähmen. NeuroTransmitter 2: 52–59
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benkert, O., Hippius, H. (2013). Medikamente zur Behandlung von sexuellen Störungen. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29810-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-29810-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29809-7
Online ISBN: 978-3-642-29810-3
eBook Packages: Medicine (German Language)